Analysis – Page 75 – Goldea Capital

Liberty Gold Reports Q1 2026 Financial and Operating Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, May 11, 2026 (GLOBE NEWSWIRE) — Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”), is pleased to announce its financial and operating results for the quarter ended March 31, 2026. All amounts are presented in United States dollars unless otherwise stated. FIRST QUARTER OF 2026 AND RECENT HIGHLIGHTS PROJECT HIGHLIGHTS – BLACK PINE During early 2026, Liberty Gold advanced the Black Pine Gold Project (“Black Pine” or the “Project”) through resource growth, continuation of a feasibility study, and key federal permitting milestones, while also executing strategic corporate initiatives.On April 3, 20261, we reported that the United States Forest Service published a Notice of Intent in the Federal Register to prepare an Environmental Impact Statement for Black Pine, initiating...

Biomea Fusion Reports First Quarter 2026 Financial Results and Corporate Highlights

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Successfully completed chronic toxicology studies for icovamenib, providing the nonclinical support for advancing to chronic clinical dosing, beyond the 12-week clinical dosing that has been used to date Topline data reported from the Phase II COVALENT-112 clinical trial of icovamenib in type 1 diabetes (“T1D”), supporting proposed mechanism of action First patients dosed in the Phase II COVALENT-211 and COVALENT-212 clinical trials of icovamenib in type 2 diabetes (“T2D”); both trials are on track with topline 26-week data expected in the fourth quarter of 2026 The Phase I GLP-131 (BMF-650) obesity clinical trial is on track; initial 28-day weight reduction data expected in the second quarter of 2026 Cash runway projected into the first quarter of 2027SAN CARLOS, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”...

Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)

Written by Customer Service on May 11, 2026. Posted in Public Companies.

Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter FORT WORTH, TX, May 11, 2026 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Summary(1)Net revenue increased 19% to $27.8 million, compared to $23.4 million in the first quarter of 2025. Gross profit of $25.9 million, or 93% of net revenue, compared to gross profit of $21.6 million, or 92% of net revenue, in the first quarter of 2025. Operating...

Midland States Bancorp, Inc. Appoints Claire Stack Chief Financial Officer

Written by Customer Service on May 11, 2026. Posted in Public Companies.

EFFINGHAM, Ill. , May 11, 2026 (GLOBE NEWSWIRE) — Midland States Bancorp, Inc. (Nasdaq: MSBI) (the “Company”) announced today that Claire A. Stack has been appointed Executive Vice President and Chief Financial Officer of the Company and Midland States Bank, its wholly-owned subsidiary (the “Bank”), effective May 8, 2026. Jeff Ludwig, President and Chief Executive Officer of the Company, commented, “Claire has earned the trust of our organization through her strong leadership, collaborative approach, and deep financial expertise. Since stepping into the interim CFO role, she has provided stability and clear direction for our finance team. I’m excited to have her step into the role permanently as we continue building a high-performing, disciplined financial organization that supports our broader strategic priorities.” Ms. Stack joined...

Exodus Reports First Quarter 2026 Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

First Quarter 2026 Revenue of $22.7 millionAnnounces closing of acquisition of Monavate and Baanx OMAHA, Neb., May 11, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus”), a leading self-custodial cryptocurrency platform, today announced its unaudited results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights (Unaudited)In USD millions, except percentages Q1 2026 Q1 2025 % ChangeRevenue $22.7 $36.0 (37%)Technology, development and user support 16.2 14.9 9%General and administrative 15.5 14.3 8%Loss on digital assets, net 36.4 28.8 (26%)Net loss $(32.1) $(12.9) (149%)Successful Closing of Monavate and Baanx AcquisitionOn May 1, 2026, Exodus announced the closing of the acquisition of the Monavate Holdings Limited (“Monavate”), Baanx US...

SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of autosomal dominant polycystic kidney disease (ADPKD)A Phase 2 proof-of-concept study of SCY-770 in ADPKD patients is anticipated to begin in Q4 2026 with an early efficacy readout anticipated in the second half of 2027Completed a private placement with net proceeds of approximately $37.2 million, after deducting placement agent fees and other transaction related expenses, with certain new and existing institutional and accredited investors. Approximately $24 million of the proceeds were received on March 31st with the balance received on April 1stSCYNEXIS announced dosing of the first patient using the intravenous (IV) formulation of SCY-247 in a Phase 1 study and plans to report topline data...

SFL – 2026 AGM Results Notification

Written by Customer Service on May 11, 2026. Posted in Public Companies.

SFL Corporation Ltd. (the “Company”) advises that the 2026 Annual General Meeting of the Shareholders of the Company was held on 11 May 2026 at 12:00 hrs at Par-la-Ville Place, 4th Floor, 14 Par-la-Ville Road, Hamilton, HM08, Bermuda (“Meeting”). The audited consolidated financial statements for the Company for the year ended 31 December 2025 were presented to the Meeting At the Meeting, the following resolutions were passed:To set the maximum number of Directors to be not more than eight.To resolve that vacancies in the number of Directors be designated as casual vacancies and that the Board of Directors be authorized to fill such vacancies as and when it deems fit.To re-elect Gary Vogel as a Director of the Company.To re-elect Keesjan Cordia as a Director of the Company.To re-elect James O’Shaughnessy as a Director of the Company.To...

STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Full year fiscal 2026 revenue from continuing operations increased 9%; constant currency organic revenue growth was 7% Full year fiscal 2026 as reported diluted EPS from continuing operations increased to $7.93; adjusted EPS per diluted share increased to $10.17 Board approves new $1 billion share repurchase programDUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter. Revenue from continuing operations for the...

Bakkt Reports First Quarter 2026 Results

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Cash and cash equivalents and restricted cash of $82.6 million as of March 31, 2026 — sufficient liquidity to execute across all three growth engines Completed the acquisition of Distributed Technologies Research (“DTR”) on April 30, 2026 in an all-stock transaction, integrating agentic AI and stablecoin payments infrastructure into the Bakkt platform Appointed Daniel Ishag as Chief Commercial Officer to lead the rebuild of Bakkt’s commercial organization across Bakkt Markets and Bakkt AgentATLANTA, May 11, 2026 (GLOBE NEWSWIRE) — Bakkt, Inc. (“Bakkt,” “Company,” “we” or “us”) (NYSE: BKKT) announced its financial and operational results for the quarter ended March 31, 2026 and provided an update on certain business developments. Management Commentary: “This quarter marks the beginning of a new chapter...

Cellectis Reports Financial Results for the First Quarter 2026

Written by Customer Service on May 11, 2026. Posted in Earnings Releases And Operating Results.

Pivotal Phase 2 with lasme-cel in r/r B-ALL (BALLI-01 trial) Pivotal Phase 2 first interim analysis expected in Q4 2026 BLA submission anticipated in 2028Phase 1 with eti-cel in r/r NHL (NATHALI-01 trial)Full Phase 1 dataset expected in Q4 2026InnovationPreclinical data on TALE-based epigenetic editing, a non-DNA cutting approach, to be presented at ASGCTServier (through Allogene): Interim pivotal data reported from the ALPHA3 trial of cema-cel (n=24)58.3% of patients in the cema-cel arm achieved MRD negativity versus 16.7% in the observation arm Favorable safety profile: no cases of CRS, ICANS, GvHD, or Treatment-Related Serious Adverse Events Study accrual expected to be completed by year-end 2027, interim EFS analysis in mid-2027, primary EFS analysis in mid-2028Cash, cash equivalents and fixed-term deposits of $188 million...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals